Alkesh Jani
Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Transplantation | 12 | 2021 | 380 | 4.750 |
Why?
| Cold Ischemia | 7 | 2021 | 21 | 3.890 |
Why?
| Organ Preservation | 5 | 2018 | 80 | 2.790 |
Why?
| Kidney | 15 | 2021 | 1187 | 2.640 |
Why?
| Apoptosis | 14 | 2021 | 2662 | 2.600 |
Why?
| Acute Kidney Injury | 11 | 2021 | 600 | 2.460 |
Why?
| Hibernation | 6 | 2016 | 80 | 2.220 |
Why?
| Kidney Tubules | 5 | 2016 | 126 | 1.840 |
Why?
| Caspase Inhibitors | 3 | 2018 | 96 | 1.600 |
Why?
| Sciuridae | 4 | 2016 | 136 | 1.450 |
Why?
| Caspase 3 | 8 | 2018 | 256 | 1.330 |
Why?
| Reperfusion Injury | 4 | 2021 | 290 | 1.310 |
Why?
| Necrosis | 4 | 2021 | 232 | 1.290 |
Why?
| Delayed Graft Function | 3 | 2018 | 16 | 1.280 |
Why?
| Rewarming | 2 | 2016 | 16 | 1.220 |
Why?
| Caspase 1 | 4 | 2021 | 149 | 1.090 |
Why?
| Warm Ischemia | 2 | 2020 | 10 | 1.000 |
Why?
| Ischemia | 6 | 2020 | 309 | 0.970 |
Why?
| Autophagy | 4 | 2016 | 307 | 0.970 |
Why?
| Organ Preservation Solutions | 2 | 2018 | 38 | 0.860 |
Why?
| Mice, Inbred C57BL | 17 | 2021 | 5232 | 0.790 |
Why?
| Inhibitor of Apoptosis Proteins | 2 | 2016 | 49 | 0.790 |
Why?
| Cold Temperature | 3 | 2016 | 157 | 0.770 |
Why?
| Amino Acid Chloromethyl Ketones | 1 | 2018 | 32 | 0.760 |
Why?
| Toll-Like Receptor 4 | 1 | 2021 | 378 | 0.720 |
Why?
| Quinolines | 1 | 2018 | 129 | 0.690 |
Why?
| Nephrectomy | 4 | 2018 | 135 | 0.630 |
Why?
| Thiones | 1 | 2015 | 18 | 0.630 |
Why?
| Arteriovenous Anastomosis | 1 | 2015 | 10 | 0.620 |
Why?
| Animals | 30 | 2021 | 35194 | 0.620 |
Why?
| Vascular Surgical Procedures | 2 | 2015 | 232 | 0.620 |
Why?
| Aorta, Abdominal | 1 | 2015 | 38 | 0.600 |
Why?
| Renal Artery | 1 | 2015 | 29 | 0.600 |
Why?
| Pyrimidinones | 1 | 2015 | 89 | 0.590 |
Why?
| Microsurgery | 1 | 2015 | 50 | 0.580 |
Why?
| Mice | 19 | 2021 | 15510 | 0.580 |
Why?
| Arousal | 2 | 2012 | 208 | 0.560 |
Why?
| Models, Animal | 4 | 2020 | 393 | 0.540 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 439 | 0.520 |
Why?
| Renin-Angiotensin System | 1 | 2013 | 88 | 0.510 |
Why?
| Creatinine | 4 | 2020 | 448 | 0.480 |
Why?
| Disease Models, Animal | 5 | 2020 | 3892 | 0.480 |
Why?
| Reperfusion | 1 | 2011 | 45 | 0.470 |
Why?
| Blood Proteins | 1 | 2012 | 264 | 0.410 |
Why?
| Adaptation, Physiological | 1 | 2013 | 535 | 0.380 |
Why?
| Body Temperature | 3 | 2013 | 280 | 0.340 |
Why?
| Tissue Donors | 3 | 2021 | 300 | 0.310 |
Why?
| Cisplatin | 4 | 2015 | 284 | 0.300 |
Why?
| Male | 19 | 2021 | 60715 | 0.280 |
Why?
| Cysteine Proteinase Inhibitors | 1 | 2004 | 60 | 0.280 |
Why?
| Kidney Failure, Chronic | 2 | 2008 | 436 | 0.270 |
Why?
| Interleukin-18 | 3 | 2013 | 241 | 0.250 |
Why?
| Swine | 2 | 2015 | 711 | 0.250 |
Why?
| Renal Circulation | 3 | 2015 | 64 | 0.240 |
Why?
| Gene Expression Regulation | 1 | 2012 | 2628 | 0.230 |
Why?
| Seasons | 3 | 2015 | 439 | 0.230 |
Why?
| Signal Transduction | 5 | 2021 | 4914 | 0.220 |
Why?
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2020 | 85 | 0.210 |
Why?
| Glomerular Filtration Rate | 2 | 2012 | 570 | 0.210 |
Why?
| Interleukin-8 | 2 | 2013 | 269 | 0.200 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2011 | 235 | 0.190 |
Why?
| Caspases | 3 | 2013 | 293 | 0.190 |
Why?
| Mice, Knockout | 4 | 2021 | 2888 | 0.190 |
Why?
| Kidney Tubular Necrosis, Acute | 2 | 2011 | 26 | 0.190 |
Why?
| Graft Rejection | 1 | 2002 | 567 | 0.190 |
Why?
| Cytokines | 5 | 2015 | 1974 | 0.180 |
Why?
| Perfusion | 2 | 2011 | 173 | 0.180 |
Why?
| Cells, Cultured | 3 | 2016 | 4413 | 0.170 |
Why?
| Epithelial Cells | 3 | 2014 | 1034 | 0.170 |
Why?
| LLC-PK1 Cells | 1 | 2015 | 7 | 0.160 |
Why?
| Cytoprotection | 1 | 2015 | 60 | 0.150 |
Why?
| Transplants | 1 | 2015 | 26 | 0.150 |
Why?
| AMP Deaminase | 1 | 2015 | 13 | 0.150 |
Why?
| Renal Artery Obstruction | 1 | 2015 | 31 | 0.150 |
Why?
| Biological Assay | 1 | 2016 | 121 | 0.150 |
Why?
| Anastomosis, Surgical | 1 | 2015 | 122 | 0.150 |
Why?
| Transfection | 2 | 2016 | 996 | 0.150 |
Why?
| Phenanthrenes | 1 | 2014 | 13 | 0.140 |
Why?
| Diterpenes | 1 | 2014 | 36 | 0.140 |
Why?
| Macrolides | 1 | 2014 | 65 | 0.140 |
Why?
| Species Specificity | 1 | 2016 | 649 | 0.140 |
Why?
| Phosphorylation | 2 | 2016 | 1740 | 0.140 |
Why?
| AMP-Activated Protein Kinases | 1 | 2015 | 150 | 0.140 |
Why?
| Immunohistochemistry | 2 | 2012 | 1828 | 0.140 |
Why?
| RNA Interference | 1 | 2016 | 514 | 0.130 |
Why?
| Physiology, Comparative | 1 | 2013 | 5 | 0.130 |
Why?
| Antineoplastic Agents | 3 | 2014 | 2048 | 0.130 |
Why?
| Cell Line | 2 | 2018 | 3013 | 0.130 |
Why?
| Ursidae | 1 | 2012 | 11 | 0.130 |
Why?
| Biomarkers | 4 | 2018 | 3464 | 0.130 |
Why?
| Acute-Phase Proteins | 1 | 2013 | 69 | 0.130 |
Why?
| Lipocalins | 1 | 2013 | 39 | 0.130 |
Why?
| Nephrology | 1 | 2012 | 29 | 0.130 |
Why?
| alpha-Macroglobulins | 1 | 2012 | 24 | 0.120 |
Why?
| Thrombosis | 1 | 2015 | 264 | 0.120 |
Why?
| Blotting, Western | 2 | 2012 | 1316 | 0.120 |
Why?
| Serum Albumin | 1 | 2012 | 161 | 0.110 |
Why?
| Raffinose | 1 | 2011 | 20 | 0.110 |
Why?
| bcl-X Protein | 1 | 2011 | 45 | 0.110 |
Why?
| Sus scrofa | 1 | 2011 | 55 | 0.110 |
Why?
| CD4-Positive T-Lymphocytes | 2 | 2015 | 1063 | 0.110 |
Why?
| DNA Primers | 1 | 2012 | 597 | 0.110 |
Why?
| Tissue and Organ Harvesting | 1 | 2011 | 63 | 0.110 |
Why?
| Allopurinol | 1 | 2011 | 88 | 0.110 |
Why?
| Polycystic Kidney Diseases | 1 | 2011 | 50 | 0.110 |
Why?
| Chromatography, Liquid | 1 | 2012 | 344 | 0.110 |
Why?
| Death | 1 | 2011 | 82 | 0.110 |
Why?
| Adipose Tissue | 1 | 2015 | 662 | 0.110 |
Why?
| Hemodynamics | 1 | 2015 | 1097 | 0.110 |
Why?
| Chemokine CXCL1 | 4 | 2012 | 73 | 0.110 |
Why?
| Tandem Mass Spectrometry | 1 | 2012 | 395 | 0.100 |
Why?
| Macrophages | 3 | 2013 | 1338 | 0.100 |
Why?
| Interleukins | 1 | 2011 | 235 | 0.100 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 1125 | 0.100 |
Why?
| Adenosine | 1 | 2011 | 216 | 0.100 |
Why?
| Treatment Outcome | 3 | 2015 | 8944 | 0.100 |
Why?
| Glutathione | 1 | 2011 | 364 | 0.100 |
Why?
| Metabolic Syndrome | 1 | 2013 | 384 | 0.090 |
Why?
| Carrier Proteins | 1 | 2013 | 820 | 0.090 |
Why?
| Receptors, Interleukin-8B | 1 | 2008 | 22 | 0.090 |
Why?
| Cyst Fluid | 1 | 2008 | 26 | 0.090 |
Why?
| Proto-Oncogene Proteins | 1 | 2013 | 712 | 0.090 |
Why?
| Dendritic Cells | 1 | 2012 | 489 | 0.090 |
Why?
| Cysts | 1 | 2008 | 84 | 0.090 |
Why?
| Kidney Glomerulus | 2 | 2011 | 122 | 0.080 |
Why?
| Renal Insufficiency, Chronic | 1 | 2012 | 461 | 0.080 |
Why?
| Postoperative Complications | 2 | 2015 | 2095 | 0.080 |
Why?
| Kidney Diseases | 2 | 2008 | 396 | 0.080 |
Why?
| Liver Transplantation | 1 | 2013 | 706 | 0.080 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 374 | 0.080 |
Why?
| Proteomics | 1 | 2012 | 759 | 0.080 |
Why?
| Liver Diseases | 1 | 2008 | 270 | 0.070 |
Why?
| Polycystic Kidney, Autosomal Dominant | 1 | 2008 | 186 | 0.070 |
Why?
| Thermosensing | 1 | 2004 | 14 | 0.070 |
Why?
| Kidney Cortex | 1 | 2004 | 27 | 0.070 |
Why?
| Caspase 2 | 1 | 2004 | 16 | 0.070 |
Why?
| Caspase 8 | 1 | 2004 | 59 | 0.070 |
Why?
| Caspase 9 | 1 | 2004 | 55 | 0.070 |
Why?
| DNA Fragmentation | 1 | 2004 | 62 | 0.070 |
Why?
| Microvilli | 1 | 2004 | 63 | 0.070 |
Why?
| Kidney Function Tests | 2 | 2015 | 159 | 0.070 |
Why?
| In Situ Nick-End Labeling | 1 | 2004 | 138 | 0.070 |
Why?
| Calpain | 1 | 2004 | 59 | 0.070 |
Why?
| Scleroderma, Systemic | 1 | 2004 | 89 | 0.070 |
Why?
| p38 Mitogen-Activated Protein Kinases | 2 | 2015 | 314 | 0.070 |
Why?
| Liver | 2 | 2015 | 1859 | 0.070 |
Why?
| Acute Disease | 2 | 2008 | 997 | 0.070 |
Why?
| Immunoblotting | 1 | 2004 | 375 | 0.070 |
Why?
| Humans | 12 | 2016 | 112249 | 0.060 |
Why?
| Pancreas Transplantation | 1 | 2003 | 54 | 0.060 |
Why?
| Calcineurin Inhibitors | 1 | 2003 | 64 | 0.060 |
Why?
| Neoplasms | 1 | 2015 | 2009 | 0.060 |
Why?
| Sirolimus | 1 | 2003 | 181 | 0.060 |
Why?
| Temperature | 1 | 2004 | 665 | 0.060 |
Why?
| Neutrophil Infiltration | 2 | 2013 | 110 | 0.060 |
Why?
| Insulin | 1 | 2011 | 2167 | 0.050 |
Why?
| Reference Values | 1 | 2002 | 876 | 0.050 |
Why?
| Interleukin-1beta | 2 | 2013 | 415 | 0.050 |
Why?
| Cell Proliferation | 1 | 2008 | 2400 | 0.050 |
Why?
| TRPP Cation Channels | 2 | 2011 | 67 | 0.050 |
Why?
| Risk Factors | 2 | 2013 | 8978 | 0.050 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 908 | 0.040 |
Why?
| Flow Cytometry | 2 | 2011 | 1184 | 0.040 |
Why?
| Time Factors | 2 | 2004 | 7054 | 0.040 |
Why?
| Lymphocyte Depletion | 1 | 2015 | 138 | 0.040 |
Why?
| Gene Knockout Techniques | 1 | 2015 | 118 | 0.040 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2015 | 170 | 0.040 |
Why?
| Peroxidase | 1 | 2015 | 207 | 0.040 |
Why?
| Homozygote | 1 | 2015 | 202 | 0.040 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 175 | 0.040 |
Why?
| Tumor Burden | 1 | 2015 | 281 | 0.040 |
Why?
| MAP Kinase Kinase 4 | 1 | 2014 | 26 | 0.040 |
Why?
| Endothelial Cells | 2 | 2011 | 641 | 0.030 |
Why?
| Epoxy Compounds | 1 | 2014 | 46 | 0.030 |
Why?
| Adult | 5 | 2013 | 31789 | 0.030 |
Why?
| Interleukin-1alpha | 1 | 2013 | 58 | 0.030 |
Why?
| Cell Line, Tumor | 2 | 2013 | 2919 | 0.030 |
Why?
| Lipocalin-2 | 1 | 2013 | 58 | 0.030 |
Why?
| Uremia | 1 | 2012 | 19 | 0.030 |
Why?
| Obesity, Abdominal | 1 | 2013 | 34 | 0.030 |
Why?
| Kidney Tubules, Proximal | 1 | 2013 | 92 | 0.030 |
Why?
| Clodronic Acid | 1 | 2012 | 12 | 0.030 |
Why?
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2013 | 139 | 0.030 |
Why?
| MAP Kinase Signaling System | 1 | 2014 | 319 | 0.030 |
Why?
| Cholesterol, HDL | 1 | 2013 | 235 | 0.030 |
Why?
| Thromboembolism | 1 | 2012 | 104 | 0.030 |
Why?
| Diphtheria Toxin | 1 | 2012 | 69 | 0.030 |
Why?
| Fatty Acids | 1 | 2015 | 420 | 0.030 |
Why?
| Chemokine CCL2 | 1 | 2012 | 133 | 0.030 |
Why?
| Interleukin-33 | 1 | 2011 | 37 | 0.030 |
Why?
| Middle Aged | 4 | 2013 | 28676 | 0.030 |
Why?
| Oxidation-Reduction | 1 | 2015 | 1045 | 0.030 |
Why?
| Beclin-1 | 1 | 2011 | 15 | 0.030 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 165 | 0.030 |
Why?
| Cholesterol, LDL | 1 | 2013 | 323 | 0.030 |
Why?
| Female | 4 | 2013 | 62624 | 0.030 |
Why?
| Computer Simulation | 1 | 2016 | 943 | 0.030 |
Why?
| Lipid Metabolism | 1 | 2015 | 533 | 0.030 |
Why?
| Microscopy, Electron, Transmission | 1 | 2011 | 145 | 0.030 |
Why?
| Triglycerides | 1 | 2013 | 542 | 0.030 |
Why?
| Osteoporosis | 1 | 2012 | 194 | 0.030 |
Why?
| Fluorescent Antibody Technique | 1 | 2011 | 440 | 0.030 |
Why?
| Glucose | 1 | 2015 | 866 | 0.030 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2011 | 218 | 0.030 |
Why?
| Wound Healing | 1 | 2012 | 324 | 0.030 |
Why?
| Microtubule-Associated Proteins | 1 | 2011 | 213 | 0.020 |
Why?
| Blood Urea Nitrogen | 1 | 2008 | 63 | 0.020 |
Why?
| Mice, Inbred BALB C | 1 | 2012 | 1326 | 0.020 |
Why?
| CD11b Antigen | 1 | 2008 | 72 | 0.020 |
Why?
| Chemokine CXCL5 | 1 | 2008 | 15 | 0.020 |
Why?
| Colorado | 2 | 2013 | 4552 | 0.020 |
Why?
| Cell Shape | 1 | 2008 | 58 | 0.020 |
Why?
| Cell Count | 1 | 2008 | 333 | 0.020 |
Why?
| Estradiol | 1 | 2011 | 450 | 0.020 |
Why?
| Comorbidity | 1 | 2013 | 1597 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2013 | 1926 | 0.020 |
Why?
| Chemokines | 1 | 2008 | 237 | 0.020 |
Why?
| Cell Polarity | 1 | 2008 | 136 | 0.020 |
Why?
| Interleukin-1 | 1 | 2012 | 1045 | 0.020 |
Why?
| Cell Hypoxia | 1 | 2008 | 238 | 0.020 |
Why?
| Incidence | 1 | 2013 | 2453 | 0.020 |
Why?
| Stress, Mechanical | 1 | 2008 | 472 | 0.020 |
Why?
| Blood Pressure | 1 | 2013 | 1755 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2013 | 2877 | 0.020 |
Why?
| Insulin Resistance | 1 | 2013 | 1140 | 0.020 |
Why?
| Cadaver | 1 | 2004 | 269 | 0.020 |
Why?
| Genetic Predisposition to Disease | 1 | 2013 | 2406 | 0.020 |
Why?
| Muscle, Skeletal | 1 | 2012 | 1406 | 0.020 |
Why?
| Living Donors | 1 | 2004 | 196 | 0.020 |
Why?
| Graft Survival | 1 | 2004 | 392 | 0.020 |
Why?
| Hospitals, University | 1 | 2003 | 195 | 0.020 |
Why?
| Cyclosporine | 1 | 2003 | 185 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2008 | 1260 | 0.020 |
Why?
| Mice, Transgenic | 1 | 2008 | 2159 | 0.020 |
Why?
| Tacrolimus | 1 | 2003 | 143 | 0.020 |
Why?
| Rats | 1 | 2011 | 6372 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2013 | 6778 | 0.010 |
Why?
| Survival Analysis | 1 | 2004 | 1414 | 0.010 |
Why?
| Transcription, Genetic | 1 | 2008 | 1473 | 0.010 |
Why?
| Aged | 2 | 2013 | 20025 | 0.010 |
Why?
| Drug Therapy, Combination | 1 | 2003 | 999 | 0.010 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2013 | 2001 | 0.010 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2008 | 2029 | 0.010 |
Why?
| Skin | 1 | 2004 | 694 | 0.010 |
Why?
| Immunosuppressive Agents | 1 | 2003 | 673 | 0.010 |
Why?
| Retrospective Studies | 2 | 2004 | 11118 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2003 | 2226 | 0.010 |
Why?
| Young Adult | 1 | 2013 | 10899 | 0.010 |
Why?
| Adolescent | 1 | 2013 | 18577 | 0.010 |
Why?
| United States | 1 | 2004 | 12170 | 0.010 |
Why?
|
|
Jani's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|